Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
1,852 questions in 128 reviews · Effective Practice and Organisation of Care
current versionsNo studies 557 · 30.1%Ungraded 53 · 2.9%Very low 446 · 24.1%Low 476 · 25.7%Moderate 255 · 13.8%High 65 · 3.5%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Number of participants waiting longer than recommended · patients scheduled for elective surgery Interventions to reduce waiting times for elective procedures (2015) · Cochrane | no estimate extracted | 1 participants | Very low |
Intervention NR Waiting time · patients needing elective specialist ambulatory visit or surgery Interventions to reduce waiting times for elective procedures (2015) · Cochrane | no estimate extracted | 2 studies · 123 participants | Low |
Intervention NR Proportion of participants waiting below a recommended time threshold · patients needing elective specialist ambulatory visit or surgery Interventions to reduce waiting times for elective procedures (2015) · Cochrane | no estimate extracted | 1 participants | Very low |
Intervention NR Distant consultancy · patients needing elective specialist ambulatory visit or surgery Interventions to reduce waiting times for elective procedures (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Waiting time  · patients needing elective specialist ambulatory visit or surgery Interventions to reduce waiting times for elective procedures (2015) · Cochrane | no estimate extracted | 1 study · 10 participants | Low |
Intervention NR Generic waiting list · patients needing elective specialist ambulatory visit or surgery Interventions to reduce waiting times for elective procedures (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Number of participants waiting less than recommended time threshold or within a recommended time period · patients needing elective specialist ambulatory visit or surgery Interventions to reduce waiting times for elective procedures (2015) · Cochrane | no estimate extracted | 1 participants | Very low |
Intervention NR Serious MEs (ICU) Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR MEs Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Harmful ADEs Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Potentially harmful ADEs Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR BCMA vs no BCMA Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Targeted preventable ADEs Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Potential ADEs Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Technical prescribing MEs Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Clinical prescribing MEs Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Potentially harmful MEs Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR aPrescriptions. Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Serious MEs (medical ward) Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Serious MEs (surgical ward) Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Length of stay in days (mean and SD) Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Costs of drugsd ($: number of participants) Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Costs of hospitalisation ($: number of participants) Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR CPOE vs no CPOE Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Non‐intercepted serious MEs Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Preventable ADEs (harm) Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Drug use (item per patient or prescription) Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Healthcare utilisation Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health outcomes Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Drug use (generic percentage) Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Costs per item Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Costs per patient or prescription Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Total costs Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Healthcare utilisation (referral to outpatient specialists) Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Health outcomes Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Drug use Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Costs Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Medicine use · vulnerable and general populations Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Overall healthcare utilisation · vulnerable and general populations Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Emergency department and hospitalisation · vulnerable and general populations Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Outpatient care · vulnerable and general populations Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Health outcomes · vulnerable and general populations Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Medicine use · vulnerable population: senior 65 years of age or older Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Overall use of medicines · vulnerable population: senior 65 years of age or older Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Use of medicines for symptomatic conditions · vulnerable population: senior 65 years of age or older Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Use of medicines for asymptomatic conditions · vulnerable population: senior 65 years of age or older Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Cost · vulnerable population: senior 65 years of age or older Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Patient perspective · vulnerable population: senior 65 years of age or older Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Overall use of medicines · vulnerable and general populations Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Insurer perspective (expenditures on medicines) · vulnerable population: senior 65 years of age or older Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines (2015) · Cochrane | no estimate extracted | NR | No studies |